Finding commercial success by integrating development, regulatory and market access strategies from the get-go
When bringing a drug to market, there is a range of scientific, clinical, regulatory and market access challenges that pharmaceutical and biotechnology companies face.
Patients are using powerful drugs and medical devices, which are extremely efficient at enhancing and saving lives, but can come with complicated side effects.
Many people take for granted that the medication they have been prescribed by their physician will adequately treat or cure their ailment. Yet the reality is that a large number...
Functional Service Providers: A flexible trial staffing model that’s capable of taking on biomarker data management
As large pharma, biotech, and medical device organizations feel the economic pinch of escalating cost, stricter regulations, and fiercer competition, many seek new ways to cut the costs of development...
Medical device and diagnostic solutions: A life cycle development model that moves your device ahead of the game
The medical device and diagnostic (MDD) industry is experiencing a transformational era due to huge advances in technologies such as AI, robotics, mobile apps, combination products and patient-enabled diagnostic tests.